Malin Boremalm (M Boremalm)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 7

Top Topics

Diffuse Large B Cell Lymphoma

Multiple Sclerosis

Top Venues

European journal of neurology

Journal of neurology

This page only lists publications with an associated author ORCID identifier.

Publications

Susanna Hallberg, Björn Evertsson, Ellen Lillvall, Malin Boremalm, Pierre de Flon, Yunzhang Wang, Jonatan Salzer, Jan N Lycke, Katharina Fink, Thomas Frisell, Faiez Al Nimer, Anders Svenningsson
Hypogammaglobulinaemia during rituximab treatment in multiple sclerosis: A Swedish cohort study. European journal of neurology 31 (8) (2024)
Susanna Hallberg, Björn Evertsson, Ellen Lillvall, Malin Boremalm, Pierre de Flon, Yunzhang Wang, Jonatan Salzer, Jan N Lycke, Katharina Fink, Thomas Frisell, Faiez Al Nimer, Anders Svenningsson
Hypogammaglobulinaemia during rituximab treatment in multiple sclerosis: A Swedish cohort study. European journal of neurology 31 (8) (2024)
Susanna Hallberg, Björn Evertsson, Ellen Lillvall, Malin Boremalm, Pierre de Flon, Yunzhang Wang, Jonatan Salzer, Jan N Lycke, Katharina Fink, Thomas Frisell, Faiez Al Nimer, Anders Svenningsson
Hypogammaglobulinaemia during rituximab treatment in multiple sclerosis: A Swedish cohort study. European journal of neurology 31 (8) (2024)
Susanna Hallberg, Björn Evertsson, Ellen Lillvall, Malin Boremalm, Pierre de Flon, Yunzhang Wang, Jonatan Salzer, Jan N Lycke, Katharina Fink, Thomas Frisell, Faiez Al Nimer, Anders Svenningsson
Hypogammaglobulinaemia during rituximab treatment in multiple sclerosis: A Swedish cohort study. European journal of neurology (2024)
Susanna Hallberg, Björn Evertsson, Ellen Lillvall, Malin Boremalm, Pierre de Flon, Yunzhang Wang, Jonatan Salzer, Jan N Lycke, Katharina Fink, Thomas Frisell, Faiez Al Nimer, Anders Svenningsson
Hypogammaglobulinaemia during rituximab treatment in multiple sclerosis: A Swedish cohort study. European journal of neurology 31 (8) (2024)
Malin Boremalm, Peter Sundström, Jonatan Salzer
Discontinuation and dose reduction of rituximab in relapsing-remitting multiple sclerosis. Journal of neurology 268 (6) (2021)
Malin Boremalm, A Juto, M Axelsson, L Novakova, T Frisell, Anders Svenningsson, Jan N Lycke, F Piehl, J Salzer
Natalizumab, rituximab and fingolimod as escalation therapy in multiple sclerosis. European journal of neurology 26 (8) (2019)